"Unitate sanitară cu paturi aflată în subordinea Ministerului Apărării Naționale"

During the past decade, Spitalul Universitar de Urgenta Militar Central "Dr. Carol Davila" conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spitalul Universitar de Urgenta Militar Central "Dr. Carol Davila"" #1 sponsor was "Pfizer" with 3 trials, followed by "Amgen" with 2 trials sponsored, "Galapagos NV" with 2 trials sponsored, "Sunovion" with 2 trials sponsored and "Actelion" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spitalul Universitar de Urgenta Militar Central "Dr. Carol Davila"" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Spitalul Universitar de Urgenta Militar Central "Dr. Carol Davila"" are "Cardiovascular Disease" (2 trials), "Crohn's Disease" (2 trials), "Schizophrenia" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Bipolar Disorder" (1 trials). Many other conditions were trialed in "Spitalul Universitar de Urgenta Militar Central "Dr. Carol Davila"" in a lesser frequency.

Most popular intervention types in "Spitalul Universitar de Urgenta Militar Central "Dr. Carol Davila"" are "Drug" (12 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Filgotinib" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Bococizumab (PF-04950615; RN316)" (1 trials) and "Cariprazine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spitalul Universitar de Urgenta Militar Central "Dr. Carol Davila"" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Spitalul Universitar de Urgenta Militar Central "Dr. Carol Davila"". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Spitalul Universitar de Urgenta Militar Central "Dr. Carol Davila", undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Spitalul Universitar de Urgenta Militar Central "Dr. Carol Davila", 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".